BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21821540)

  • 21. Potential for cancer related health services research using a linked Medicare-tumor registry database.
    Potosky AL; Riley GF; Lubitz JD; Mentnech RM; Kessler LG
    Med Care; 1993 Aug; 31(8):732-48. PubMed ID: 8336512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
    Penberthy L; Retchin SM; McDonald MK; McClish DK; Desch CE; Riley GF; Smith TJ; Hillner BE; Newschaffer CJ
    Health Care Manag Sci; 1999 Jul; 2(3):149-60. PubMed ID: 10934539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring the incidence of cancer in elderly Americans using Medicare claims data.
    McBean AM; Warren JL; Babish JD
    Cancer; 1994 May; 73(9):2417-25. PubMed ID: 8168045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring complications of cancer treatment using the SEER-Medicare data.
    Potosky AL; Warren JL; Riedel ER; Klabunde CN; Earle CC; Begg CB
    Med Care; 2002 Aug; 40(8 Suppl):IV-62-8. PubMed ID: 12187170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sepsis and Risk of Cancer Among Elderly Adults in the United States.
    Liu Z; Mahale P; Engels EA
    Clin Infect Dis; 2019 Feb; 68(5):717-724. PubMed ID: 29982318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Projections of the cost of cancer care in the United States: 2010-2020.
    Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
    J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
    McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
    Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-of-life care for lung cancer patients in the United States and Ontario.
    Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
    J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study.
    Freedman DM; Wu J; Daugherty SE; Kuncl RW; Enewold LR; Pfeiffer RM
    Int J Cancer; 2014 Oct; 135(7):1745-50. PubMed ID: 24550098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
    Lin CC; Virgo KS
    Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.
    Ascha MS; Ostrom QT; Wright J; Kumthekar P; Bordeaux JS; Sloan AE; Schumacher FR; Kruchko C; Barnholtz-Sloan JS
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):917-925. PubMed ID: 31053636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated Overview of the SEER-Medicare Data: Enhanced Content and Applications.
    Enewold L; Parsons H; Zhao L; Bott D; Rivera DR; Barrett MJ; Virnig BA; Warren JL
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):3-13. PubMed ID: 32412076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
    Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
    BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sensitivity of Medicare claims data for case ascertainment of six common cancers.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 1999 May; 37(5):436-44. PubMed ID: 10335746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage.
    Pfister DG; Rubin DM; Elkin EB; Neill US; Duck E; Radzyner M; Bach PB
    JAMA Oncol; 2015 Dec; 1(9):1303-10. PubMed ID: 26448610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of electronic data on chemotherapy and hormone therapy use in HMOs.
    Ritzwoller DP; Carroll N; Delate T; O'Keeffe-Rossetti M; Fishman PA; Loggers ET; Aiello Bowles EJ; Elston-Lafata J; Hornbrook MC
    Med Care; 2013 Oct; 51(10):e67-73. PubMed ID: 22531648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
    Butler EN; Zhou CK; Curry M; McMenamin Ú; Cardwell C; Bradley MC; Graubard BI; Cook MB
    Br J Cancer; 2023 Jan; 128(1):48-56. PubMed ID: 36307648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of SEER-Medicare data for measuring cancer surgery.
    Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemochromatosis, Iron Overload-Related Diseases, and Pancreatic Cancer Risk in the Surveillance, Epidemiology, and End Results (SEER)-Medicare.
    Julián-Serrano S; Yuan F; Barrett MJ; Pfeiffer RM; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2136-2139. PubMed ID: 34479949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.